Abdominal Obesity: Clinical Trials

1 trial for Abdominal Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Abdominal Obesity: new trials by email Literature Review of Abdominal Obesity trials Research Report on Abdominal Obesity

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension
Moxonidine, Irbesartan - Abdominal Obesity, Hypertension
Phase 4UnknownBaker Heart and Diabetes Institute1002012-01-012012-02-03

Narrower conditions

Depression (1)  ·  Hypertension (1)  ·  Obesity, Abdominal (1)

Broader conditions

Behavior (1)  ·  Behavioral Symptoms (1)  ·  Body Weight (1)  ·  Cardiovascular Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Obesity (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Irbesartan (1)  ·  moxonidine (1)

Sponsors

Baker Heart and Diabetes Institute (1)

Countries

Australia (1)